Pathogenic <scp>LRRK2</scp> compromises the subcellular distribution of lysosomes in a <scp>Rab12‐RILPL1</scp>‐dependent manner

  • Kyohei Ito
    Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences The University of Tokyo Tokyo Japan
  • Miho Araki
    Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences The University of Tokyo Tokyo Japan
  • Yuta Katai
    HACARUS, Inc. Kyoto Japan
  • Yuki Nishimura
    HACARUS, Inc. Kyoto Japan
  • Sota Imotani
    HACARUS, Inc. Kyoto Japan
  • Haruki Inoue
    HACARUS, Inc. Kyoto Japan
  • Genta Ito
    Department of Biomolecular Chemistry, Faculty of Pharma‐Science Teikyo University Tokyo Japan
  • Taisuke Tomita
    Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences The University of Tokyo Tokyo Japan

抄録

<jats:title>Abstract</jats:title><jats:p>Mutations in leucine‐rich repeat kinase 2 (LRRK2) cause familial Parkinson's disease (PD). Recent studies have shown that LRRK2 physiologically phosphorylates several Rab family proteins including Rab12 and that this phosphorylation is accelerated by the pathogenic mutations in LRRK2, although the significance in the PD pathogenesis remains unknown. Here we examined the effect of the overexpression of LRRK2 on the distribution of organelles in cultured cells and found that lysosomes become clustered in a perinuclear region upon the overexpression of pathogenic mutant LRRK2 in a manner dependent on its kinase activity. The perinuclear clustering of lysosomes was abolished by knocking out <jats:italic>RAB12</jats:italic> as well as its effector protein <jats:italic>RILPL1</jats:italic>. Re‐expression of Rab12 in <jats:italic>RAB12</jats:italic> knockout cells suggested that the phosphorylation at Ser106 of Rab12 is required for the perinuclear clustering of lysosomes. Moreover, phosphorylated Rab12 was also accumulated on the clustered lysosomes, and the phosphorylation of Rab12 increased its interaction with RILPL1, leading us to conclude that the increase in the phosphorylation of Rab12 by pathogenic LRRK2 compromised intracellular lysosomal transport via the enhanced interaction of Rab12 with RILPL1. These data suggest the involvement of abnormal regulation of lysosomal transport in the LRRK2‐mediated pathogenesis of PD.</jats:p>

収録刊行物

参考文献 (32)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

  • CRID
    1360017280635468416
  • DOI
    10.1096/fj.202200780rr
  • ISSN
    15306860
    08926638
  • データソース種別
    • Crossref
    • KAKEN

問題の指摘

ページトップへ